Shareholder Tools

Press Releases

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 1999
Press Releases
Date Title and Summary View
Aug 12, 2015 WEST LAFAYETTE, Ind., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a bio-pharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that six posters will be presented by Endocyte scienti...
Aug 4, 2015 - Dose Escalation for EC1456 and EC1169 Advance in Phase 1 Studies - - Final Overall Survival Analysis From TARGET Trial of EC145 in NSCLC to be Presented at the World Conference on Lung Cancer in September - - Conference Call Today at 4:30 p.m. EDT - WEST LAFAYETTE, Ind., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NA...
Aug 4, 2015 WEST LAFAYETTE, Ind., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that Alison A. Armour, M.B., Ch.B., B.Sc., M.Sc., M.D., M...
Aug 3, 2015 WEST LAFAYETTE, Ind., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that the company's management team will present at the 2...
Jul 28, 2015 WEST LAFAYETTE, Ind., July 28, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Tuesday, Aug. 4th, at 4:30 p.m. EDT to discuss its second quarter financial results and provide an operational update. Investors and the general public are invited to listen to a live webcast ...
Jul 1, 2015 WEST LAFAYETTE, Ind., July 1, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that the company's management team will present at the C...
May 13, 2015 WEST LAFAYETTE, Ind., May 13, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that data featuring Endocyte's SMDC, EC1456 will be prese...
May 7, 2015 - Dose Escalation for EC1456 and EC1169 Move to Fifth Dosing Cohorts Evaluating Two Schedules for Each Agent - - Conference Call Today at 4:30 p.m. EDT - WEST LAFAYETTE, Ind., May 7, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging age...
Apr 30, 2015 WEST LAFAYETTE, Ind., April 30, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc., (Nasdaq:ECYT) announced today that the company will host a conference call on Thursday, May 7, at 4:30 p.m. EDT to discuss its first quarter financial results and provide an operational update. Investors and the general public are invited to listen to a live webcast of...
Apr 10, 2015 WEST LAFAYETTE, Ind., April 10, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that four posters will be presented by Endocyte scient...
1
... NextLast
Add to Briefcase = add release to Briefcase